Abstract:Pancreatic stellate cells (PSCs) produce the stromal reaction in pancreatic cancer (PC), but their role in cancer progression has not been fully elucidated. Aims: To assess the influence of PSCs on PC growth using i) an orthotopic model of pancreatic cancer and ii) in vitro studies with cultured human PSCs and MiaPaCa2 (a human PC cell line). Methods: I) In vivo model: Athymic mice received an intrapancreatic injection of one of the following - saline (S), human PSCs (P), MiaPaCa2 cells (M), or human PSCs + MiaPaCa2 (1:1; P+M). After 7 weeks, mice were killed and tumor size and tumor spread assessed. Tumor histology was assessed with H&E, cytokeratin and α smooth muscle actin (αSMA) staining. II) In vitro studies: Effect of PSC secretions (from 3 separate human PSC preparations) on (a) PC cell proliferation - assessed by incorporation of 3H-thymidine into DNA of MiaPaCa2 cells incubated with PSC secretions for 24, 48 and 72h; (b) PC cell apoptosis - TUNEL staining used to assess basal and H2O2-stimulated MiaPaCa2 cell apoptosis, in the presence and absence of PSC secretions. Results: I) Orthotopic model: Mice injected with PSCs+MiaPaCa2 exhibited increased tumor size (Fig 1) and local and distant spread (Fig 2) compared to mice receiving MiaPaCa2 cells alone. No tumors were found in mice injected with PSCs alone. Morphometry of cytokeratin stained sections showed significantly higher epithelial cell numbers in the P+M group tumors compared to those in group M. αSMA staining revealed activated PSCs in fibrotic bands in P+M tumors with negligible staining in the other 3 groups. II) In vitro studies: (a) MiaPaCa2 proliferation was increased upon exposure to PSC secretions [24h - 217.4 ± 29.5*, 48h - 195.5±15.8*, 72h - 245.6±44.5* % of control; *p < 0.005]. (b) MiaPaCa2 apoptosis - Both basal and H2O2 stimulated apoptosis of MiaPaCa2 cells was significantly inhibited by PSC secretions. [Data as fold change: basal apoptosis 1; PSC secretions 0.45±0.05*, H2O2 16.39± 2.34**; H2O2+PSC secretions 3.59±0.81*; *p < 0.01].FIGURE 1: Primary tumour size. *p > 0.04: n = 5 mice/group.FIGURE 2: Local and distant spread. *p > 0.055: n = 5 mice/group.Conclusions: i) Pancreatic tumor growth and metastasis are significantly increased in mice receiving PSCs+MiaPaCa2 compared to those receiving MiaPaCa2 alone. The increase in tumor size is due to increased tumor cell number and not merely to fibrosis. ii) PSC secretions induce proliferation and inhibit apoptosis of PC cells. Implications: PSCs establish an environment that promotes tumor progression by stimulating proliferation and reducing apoptosis of pancreatic cancer cells.

Pessolano et al. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System. Int. J. Mol. Sci. 2018, 19, 3878

Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors

Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cells

ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progression and Metastasis

[Expression of Annexin I in Human Pancreatic Cancer and the Influence of Its Down-Regulation on Biology of This Cancer].

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

Exploring the Immunomodulatory Potential of Pancreatic Cancer-Derived Extracellular Vesicles through Proteomic and Functional Analyses

Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer

PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC

Anti-cancer activity of Annexin V in murine melanoma model by suppressing tumor angiogenesis.

MiR-519a/522-5p from Pancreatic Cancer-Secreted Exosomes Promotes Tumor Invasion by Enhancing Warburg Effect

Exploring Unique Extracellular Vesicles Associated Signatures: Prognostic Insights, Immune Microenvironment Dynamics, and Therapeutic Responses in Pancreatic Adenocarcinoma

The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer

PANCREATIC STELLATE CELLS STIMULATE PANCREATIC CANCER GROWTH AND METASTASIS

Abstract 1600: Interception of pro-tumorigenic glycan signaling in pancreatic cancer

Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway

Advances in cancer treatment: a new therapeutic target, Annexin A2

Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy

nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer

Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks

Oncogenic and Non-Malignant Pancreatic Exosome Cargo Reveal Distinct Expression of Oncogenic and Prognostic Factors Involved in Tumor Invasion and Metastasis